BRCA1 and neoplasm: TNBC tumours are characterised by highly rearranged genomes and closely linked to mutations in high-risk breast cancer genes like BRCA1 and BRCA2. The latter links TNBC with DNA repair deficiency, such as homologous recombination deficiency (HRD), which has been associated with improved prognosis after adjuvant chemotherapy3,4.